Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
28,264,074
-
Share change
-
+5,128,454
-
Total reported value
-
$1,179,961,869
-
Put/Call ratio
-
85%
-
Price per share
-
$41.74
-
Number of holders
-
171
-
Value change
-
+$217,785,949
-
Number of buys
-
107
-
Number of sells
-
60
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2022
As of 30 Sep 2022,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,264,074 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., MACQUARIE GROUP LTD, VANGUARD GROUP INC, Sandhill Capital Partners LLC, CREDIT SUISSE AG/, DRIEHAUS CAPITAL MANAGEMENT LLC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, NEXT CENTURY GROWTH INVESTORS LLC, and LORD, ABBETT & CO. LLC.
This page lists
172
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.